Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

Guided fluid removal using VeXUS score for patients with acute kidney injury after heart surgery

Official title: Feasibility of a Randomised Trial Comparing a Fluid-removal Guided by VeXUS Score With Usual Care in Patients With Acute Kidney Injury After Cardiac Surgery: a Pilot Randomised Trial.

Run by Hospices Civils de Lyon · NCT06251713 · Data updated 2026-11-12

This study is testing if using the VeXUS score to manage fluid levels can help patients with acute kidney injury after heart surgery recover better than standard care.

More Acute Kidney Injury trials

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment40 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations2 sites (Bron, Bron and 1 other locations)
StatusRecruiting
StartedJuly 31, 2024
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedJuly 24, 2026
Trial IDNCT06251713 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients admitted to the ICU within 72 hours of cardiac surgery who meet the KDIGO criteria for acute kidney injury.

Probably not a fit

Patients with severe pre-existing kidney disease or those requiring immediate renal replacement therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of the VeXUS score, an ultrasound-based assessment of venous congestion, to guide fluid management in patients who have developed acute kidney injury following cardiac surgery. The goal is to determine if this targeted approach can improve patient outcomes compared to standard care. Participants will be those admitted to the intensive care unit within 72 hours post-surgery and diagnosed with acute kidney injury. The study aims to address the challenges of fluid management in this vulnerable population, where both dehydration and fluid overload can be harmful.

Why it matters

Potential benefit: If successful, this approach could lead to improved kidney recovery and reduced mortality in patients after cardiac surgery.

How similar studies have gone: While the use of ultrasound scores in fluid management is gaining traction, this specific application of the VeXUS score is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Intensive care unit admission within 72 hours of cardiac surgery with extracorporeal circulation
* Acute kidney injury defined by KDIGO criteria
* Vasoactive inotropic score \<45 and capillary refill time \<3s
* Informed written consent

Exclusion Criteria:

* Hypokalaemia \<3.5mmol/L
* Hyponatremia\<125mmol/L
* Hypernatremia \>145mmol/L
* Metabolic alkalosis with pH \>7.50
* Impossibility to measure capillary refill time
* Chronic liver disease
* Cirrhosis with portal hypertension
* Known thrombus of the inferior vena cava
* Mechanical circulatory assistance (ECMO or mono left ventricular assistance)
* Severe pre-operative chronic kidney disease (GFR \< 30mL/min/1.73m2)
* Need for renal replacement therapy anticipated by the attending physician within 24 hours
* Known hypersensitivity to Furosemide and/or hydrochlorothiazide
* Severe allergy to wheat
* Patient already included in another interventional study with an exclusion period still in progress
* Pregnant, breast-feeding or women of childbearing age without suitable contraception
* Patients under guardianship, curatorship or safeguard of justice
* Patients under psychiatric care
* Patients not affiliated to a social security scheme or beneficiaries of a similar scheme

Where it's running

  • Hopital cardiologique Louis Pradel
    Bron, France
    Recruiting
  • Hôpital Louis Pradel, Groupement Hospitalier Est, Hospices Civils de Lyon
    Bron, Bron, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.